Agency Information Collection Activities: Proposed Collection; Comment Request; Reinstatement
FDA is reinstating a proposed information collection under the Paperwork Reduction Act, likely related to MoCRA compliance (facility registration, product listing, etc.). Public comments are due by the deadline specified in the notice.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All cosmetics businesses (indie brands, contract manufacturers, private-label makers, importers/distributors) subject to MoCRA. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Check the Federal Register notice for the exact comment deadline (typically 60 days from publication).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA is reopening the comment period for a previously proposed information collection, which may affect the scope or requirements of MoCRA compliance (e.g., registration, listing, safety substantiation).
Who it affects
All cosmetics businesses (indie brands, contract manufacturers, private-label makers, importers/distributors) subject to MoCRA.
What you must do
Review the proposed collection and submit comments to FDA before the deadline to influence final requirements.
Deadline
Check the Federal Register notice for the exact comment deadline (typically 60 days from publication).
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
- FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
- FDA Expands AI Capabilities and Completes Data Platform Consolidation
- FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection